The association between local atherosclerosis of the prostatic artery and benign prostatic enlargement in humans: Putative mechanism of chronic ischemia for prostatic enlargement
Authors:
- 21 May 2018
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 78 (13) , 1001-1012
Abstract
Background: To investigate the possible pathogenesis of the benign prostatic enlargement (BPE) induced by local atherosclerosis, the association between local atherosclerosis and prostatic enlargement was investigated, and molecular biological analyses were performed using human prostatectomy specimens.Methods: A total of 69 consecutive patients who underwent robot‐assisted radical prostatectomy (RARP) participated in this prospective study. To evaluate actual local atherosclerosis, prostatic arteries were removed during RARP. Microscopic assessment of local atherosclerosis was classified as one of three degrees of narrowing (minimal, moderate, and severe) according to the degree of obstruction of the inner cavity of the prostatic artery. The expressions of several mediators related to chronic ischemia and cell proliferation of the prostate were investigated by immunohistochemistry.Results: The median age of the present cohort was 68 (range: 55‐75) years. Although there was no relationship between local atherosclerosis and lower urinary symptoms evaluated by questionnaires, local atherosclerosis was significantly more severe in patients who had a history of treatment for benign prostatic hyperplasia (P = 0.02). Prostate size was significantly larger in the severe local atherosclerosis group than in the minimal and moderate local atherosclerosis groups (P < 0.001 and P = 0.03, respectively). Thepositive expression rates of hypoxia‐inducible factor (HIF)‐1α, malondialdehyde (MDA), transforming growth factor (TGF)‐β1, and basic fibroblast growth factor (bFGF) in the prostate were significantly higher in patients with local atherosclerosis than in patients without local atherosclerosis (all P < 0.01, respectively).Conclusions: In human surgical specimens, there is evidence that local atherosclerosis of the prostatic artery is significantly associated with prostate size. Given the molecular evidence provided in this study, the putative mechanism for this relationship is that chronic ischemia induced upregulation of oxidative stress pathways, leading to BPE.Keywords
This publication has 26 references indexed in Scilit:
- Impaired Detrusor Contractility in a Rat Model of Chronic Bladder IschemiaUrology, 2013
- The impact of atherosclerosis on lower urinary tract functionThe Aging Male, 2013
- The Correlation Between Metabolic Syndrome and Prostatic DiseasesEuropean Urology, 2012
- The effect of atherosclerosis‐induced chronic bladder ischemia on bladder function in the ratNeurourology and Urodynamics, 2011
- Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort studyThe Lancet Oncology, 2008
- Atherosclerosis as a risk factor for benign prostatic hyperplasiaBJU International, 2006
- Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom scoreUrology, 2006
- Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunctionBJU International, 2005
- Benign prostatic hyperplasia: age-related tissue-remodelingExperimental Gerontology, 2005
- The thin intima of the internal mammary artery as the possible reason for freedom from atherosclerosis and success in coronary bypassAmerican Heart Journal, 1991